Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 1999, p. 1591-1594, Vol. 43, No. 7
Anaerobe Reference
Laboratory1 and Department of
Vaccines,
Received 2 September 1998/Returned for modification 16 December
1998/Accepted 17 April 1999
The frequency of Previous reports of The aim of the present longitudinal study was to examine the
age-related frequency of Subjects.
The original study population, from whom 50 consecutive healthy infants were chosen for a detailed bacteriologic
investigation, comprised 329 children participating in the Finnish
Otitis Media Cohort Study in Tampere, Finland, from 1994 to 1997. The
infants attended scheduled visits at the study clinic, where bacterial samples were collected and a wide variety of background data was gathered by interviewing the parent(s). If an infant became sick between the visits, the infection was treated in the same clinic, which
provided the information of the antimicrobial history. Forty-four Caucasian infants, 2, 6, and 12 months of age, with complete
bacteriologic and demographic data were included in the present study.
Bacterial samples and culture.
During the scheduled visits,
unstimulated saliva samples (0.1 to 0.3 ml) were collected from the
cheek area with a calibrated plastic pipette. The measured samples were
placed in VMGA III transport medium (5), delivered to the
laboratory by overnight mail, and processed within 24 h.
Testing of Statistics.
The statistical significance of the association
between the amount of During the infants' (n = 44) first year of life,
the occurrence of
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
-Lactamase Production by Oral Anaerobic
Gram-Negative Species in Infants in Relation to Previous
Antimicrobial Therapy
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactamase production in gram-negative bacteria
has increased considerably during recent years. In this study,
-lactamase production by oral anaerobic gram-negative rods isolated
from saliva was longitudinally examined for 44 Caucasian infants at the
ages of 2, 6, and 12 months in relation to their documented exposure to
antibiotics. Isolates showing decreased susceptibility to penicillin G
(1 µg/ml) were examined for
-lactamase production by using a
chromogenic cephalosporin disk test.
-Lactamase-positive, gram-negative anaerobic species were found in 11, 55, and 89% of each
age group, respectively.
-Lactamase production was most frequent
among organisms of the Prevotella melaninogenica group. At
12 months, 73% of the infants harbored
-lactamase-producing members
of the P. melaninogenica group, 55% had nonpigmented
Prevotella species, 25% had Porphyromonas
catoniae, 23% had Fusobacterium nucleatum, and 5%
had Capnocytophaga species. Several
-lactamase-producing species could be simultaneously found in the infants' mouths. The
presence of
-lactamase-producing species was significantly associated with the infants' exposure to antibiotics through
antimicrobial treatments given to the infants and/or their mothers.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-Lactamases are enzymes that
hydrolyze the
-lactam ring of a
-lactam drug, leading to the
inactivation of the drug. This is the most common resistance mechanism,
especially among the gram-negative bacteria (7). Until the
latter half of the 1970s, penicillins and cephalosporins were in most
cases still effective against oral gram-negative anaerobes. In 1977, Murray and Rosenblatt (16) reported a frequency of
-lactamase production by Bacteroides melaninogenicus (now
reclassified as Prevotella melaninogenica and several other
pigmented gram-negative rods) exceeding 56%. During the 1980s and
1990s, the production of
-lactamases by these bacteria steadily
increased. Anaerobic gram-negative rods, including
Prevotella, Porphyromonas, and
Fusobacterium species, can be involved in pyogenic orofacial
and upper respiratory tract infections. These organisms may also
protect otherwise-susceptible pathogens from a
-lactam agent, which
in turn leads to a failure of penicillin treatment (6).
Cases of clinical failure with penicillin treatment for human orofacial
infections have been documented along with reports suggesting that
previous penicillin therapy increases the incidence of
penicillin-resistant bacteria in the oral cavity (2, 3, 8,
23).
-lactamase production have been based mainly on
hospitalized adults and children. To our knowledge
-lactamase production has not been studied for healthy infants in a nonhospital setting. Otitis media, among other upper respiratory tract infections, is one of the most common infections in childhood (22). This infection is often treated with antimicrobial agents, especially
-lactam antibiotics. Therefore, if antibiotic use provokes
-lactamase production (7), it would be reasonable to
assume that young children easily harbor
-lactamase-producing
strains. Indeed, previous studies (12, 13) have shown that
-lactamase production by certain groups of oral anaerobes in early
childhood can be much more frequent than generally anticipated.
-lactamase-producing oral anaerobic gram-negative species in infants during their first year of life in
relation to their exposure to antimicrobial agents.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactamase activity.
Out of 735 anaerobic
gram-negative isolates, 195 isolates showing decreased susceptibility
to penicillin G (1 µg/ml; inhibition zone
20 mm) (as determined
with special potency antibiotic disks [Oxoid, Unipath Limited,
Basingstoke, Hampshire, United Kingdom]) were included for further
examination (12).
-Lactamase production was tested by
using the qualitative chromogenic cephalosporin disk test (nitrocefin;
AB Biodisk, Solna, Sweden). The results were read after 15, 30, and 60 min.
-lactamase-producing species or groups and the
exposure to antimicrobial agents was tested by using Mantel-Haenzel
chi-square statistics. The exposure to antimicrobial agents was counted
as follows: mothers' antimicrobial courses (in 15 cases) during the 6-month period before the first sampling occasion, at 2 months of age
(maternal exposure); infants' antimicrobial courses between 2 and 6 months of age (early exposure); and infants' antimicrobial courses
between 6 and 12 months of age (late exposure).
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-lactamase-producing gram-negative anaerobic
species or groups increased with age, from 11% (5 infants) at 2 months
to 55% (24 infants) at 6 months to 89% (39 infants) at 12 months. The
mean number of
-lactamase-producing species or groups per subject
increased from 0.1 (range, 0 to 2) at 2 months to 1.8 (range, 0 to 4)
at 12 months (Table 1). The age-related
frequency and distribution of
-lactamase-producing bacteria by
species or groups are presented in Table
2. The most pronounced changes were
observed in the colonization of the Prevotella
melaninogenica group (Prevotella denticola,
Prevotella loescheii, and P. melaninogenica), which increased from 11% at 2 months to 73% at 12 months. Other
-lactamase-producing species with a frequency exceeding 20% at 12 months consisted of nonpigmented Prevotella species
(including pentose fermenters and nonfermenters), Porphyromonas
catoniae, and Fusobacterium nucleatum. The decreased
susceptibility (inhibition zone
20 mm) to penicillin (1 µg/ml), as determined with a penicillin G-impregnated disk, coincided
well with the
-lactamase production by a qualitative chromogenic
cephalosporin disk test, except for two isolates. Follow-up
colonization by
-lactamase-producing species was assessed by
comparing the positive findings obtained at 6 months with those
(positive or negative) obtained at 12 months. Fourteen of the 16 infants who at 6 months of age harbored
-lactamase-producing P. melaninogenica group isolates still harbored them at 12 months of age. Two of three infants still harbored nonpigmented
Prevotella group isolates at 12 months, and one of four
infants still harbored
-lactamase-producing P. catoniae
isolates at 12 months.
TABLE 1.
Number of infants at various ages harboring
-lactamase-producing gram-negative anaerobic species or groups
TABLE 2.
Distribution and age-related frequency of
-lactamase-producing bacterial isolates by species or groups
Thirteen infants had not been exposed to antimicrobial agents through
maternal or personal courses during their first year of life. They
harbored, on average, 1.31
-lactamase-producing species or groups
each at 12 months. Seventeen children who had had one or two exposures
to antimicrobial agents through maternal courses (antimicrobial
preparation not known) or personal courses (including
-lactams
and/or trimethoprim-sulfamethoxazole combinations intermittently)
harbored, on average, 1.82
-lactamase-producing species or groups
each. Children with three or more exposures to antimicrobial courses
(including maternal courses and
-lactams and/or
trimethoprim-sulfamethoxazole combinations intermittently) harbored, on
average, 2.21
-lactamase-producing species or groups each at 12 months. Twenty-six of the 31 children exposed to antimicrobial agents
were exposed to
-lactams. The most common indication for medication
was otitis media, and the most common antimicrobial agents used were
amoxicillin (38 courses) and a trimethoprim-sulfamethoxazole combination (28 courses). The number of antimicrobial treatments given
to the infants during their first year of life varied between 0 and 9 per infant. Six infants were on antimicrobials during one or more
sampling occasions.
A correlation between maternal antimicrobial exposure and the number of
-lactamase-producing species or groups observed in infants at the
age of 12 months was detected (P = 0.026). No positive correlation between early exposure and
-lactamase production at 12 months of age could be found. A clear correlation between late exposure
and
-lactamase-producing species or groups in infants at 12 months
of age was detected (P = 0.006) (data not shown). The
Mantel-Haenzel chi-square analyses showed a significant association between the exposure to antimicrobial agents during the first year of
life and the amount of
-lactamase-producing species at 12 months
(Table 3).
|
| |
DISCUSSION |
|---|
|
|
|---|
The frequency of
-lactamase production by anaerobic
gram-negative rods increased considerably during the first year of life of the study infants. In addition, the number of simultaneously isolated
-lactamase-producing species also increased with age. Previous antimicrobial exposures had a significant effect on the development of resistance.
The predisposing factors involved in the origin and evolution of
-lactamase production remain unclear. Almost all gram-negative rods
produce small amounts of chromosomal
-lactamases (21). However,
-lactamases encoded by genes that are transferred
extrachromosomally, as well as strong induction of chromosomal
-lactamases, have caused great clinical problems during recent
years. As reported earlier, the use of antimicrobial drugs has been
known to increase the frequency of
-lactamase production for both
anaerobes and aerobes (17, 19). Acute otitis media episodes
are especially common during the first year of life (1, 22),
and they are the main reason for antimicrobial treatment, often
recurrent, in early infancy. It is generally accepted that to limit the
spread of bacterial resistance, the use of antimicrobial agents should be controlled. To combat bacterial infections, it is necessary that the
dosage to be administered is proper, as subinhibitory concentrations
may lead to gradual development of plasmid-mediated resistance under
selection pressure or acquisition of resistance genes from other
bacteria (17). In the present study, the infants who had no
personal antibiotic history during the surveillance year or maternal
exposure before the age of 2 months harbored, on average, 1.31
-lactamase-producing species at 12 months of age. When the infants
had been exposed to antimicrobial agents (in most cases alone but in
some cases in combination with another antimicrobial agent[s]), the
number of
-lactamase-producing species increased significantly. Our
observation is well in line with that of Brook and Gober
(4), who demonstrated an increase in the number of
penicillin-resistant oropharyngeal bacteria due to the use of
amoxicillin as preventive medication against recurrent otitis media in
children. In addition to an infant's exposure to antibiotics, we also
estimated the possible influence of the mother's antimicrobial use on
the colonization of
-lactamase-producing bacteria in infants.
Indeed, bacterial transmission from mothers to infants could explain
why infants at 2 months of age whose mothers were on antimicrobial
medication harbored more
-lactamase-producing species than infants
with no exposure at all. Selection of
-lactamase-producing subpopulations and proliferation of them could explain the high incidence of resistant species at 12 months.
Plasmid-mediated resistance in the bacteria of both humans and animals
has been previously described (24). However, plasmid analysis performed for P. melaninogenica in a previous study
(12) showed no correlation between the production of
-lactamase and the presence of plasmids. It has been suggested that
genes that encode resistance to tetracyclines and penicillin from
anaerobes from different families and species may be transferred
together to the host (18, 24). However, according to a
recent study (14),
-lactamase-producing F. nucleatum isolates from young children were resistant to
penicillin G (MICs, 2 to 256 µg/ml) but susceptible to tetracycline
hydrochloride. The factors behind
-lactamase production need to be
investigated further. Aspects of special interest would be the
composition of the oral microflora and the antimicrobial drug history
of the family members. Special attention should be paid to children in
day care, as they are more likely to be exposed to and transmit early
acute otitis media to their infant siblings (15).
According to a previous study (11), strain turnover may
easily occur in young children with a developing oral ecosystem. In
this study, some of the infants who harbored
-lactamase-producing isolates at 6 months did not harbor them at 12 months. It is possible that a turnover of the bacterial population in the biological environment, from
-lactamase-positive strains to
-lactamase-negative strains, had occurred or that methodologic
biases included adverse factors inherent in the sampling efficacy or
merely in the ability to isolate the index species from mixed cultures.
However, to evaluate the stability of a strain, genetic methods (e.g.,
ribotyping, arbitrarily primed PCR, or an equivalent method) should be
used to document the degree of clonal similarity.
One of the explanations for the high frequency of
-lactamase
production is certainly the fact that P. melaninogenica is a genotypically heterogeneous species (11), which means that
one individual can simultaneously harbor several strains with different characteristics, in this case both
-lactamase-positive and
-lactamase-negative strains, and with indistinguishable genotypes
(12). Therefore, in this study several isolates per infant,
if available, were tested for
-lactamase production, because if only
one isolate per infant had been tested, the true rate of colonization
by
-lactamase-producing strains might have been underestimated.
The child's immediate environment and close contacts have a great
influence on the development of the early oral microflora. On the basis
of the present investigation, we conclude that the high frequency of
-lactamase-producing bacterial strains reflects the net effect of
the child's and the family members', especially the mother's,
antibiotic exposure.
| |
ACKNOWLEDGMENTS |
|---|
We thank Ritva Syrjänen, Marja-Leena Hotti, Mervi Martola, and Päivi Tervonen for clinical monitoring; Arja Kanervo and Eveliina Tarkka for assistance with identification of bacterial isolates; Merja Rautio for technical assistance; and Eeva Koskenniemi and Jorma Torppa for statistical analysis.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: National Public Health Institute, Anaerobe Reference Laboratory, Mannerheimintie 166, FIN-00300 Helsinki, Finland. Phone: 358-9-47448248. Fax: 358-9-47448238. E-mail: Eija.Kononen{at}ktl.fi.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alho, O. P., M. Koivu, M. Sorri, and P. Rantakallio. 1991. The occurrence of acute otitis media in infants: a life-table analysis. Int. J. Pediatr. Otorhinolaryngol. 21:7-14[Medline]. |
| 2. |
Brook, I.,
L. Calhoun, and P. Yocum.
1980.
Beta-lactamase-producing isolates of Bacteroides species from children.
Antimicrob. Agents Chemother.
18:164-166 |
| 3. |
Brook, I., and A. E. Gober.
1995.
Role of bacterial interference and -lactamase-producing bacteria in the failure of penicillin to eradicate group A-streptococcal pharyngotonsillitis.
Arch. Otolaryngol. Head Neck Surg.
121:1405-1409.
|
| 4. | Brook, I., and A. E. Gober. 1996. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin. Infect. Dis. 22:143-145[Medline]. |
| 5. | Dahlén, G., P. Pipattanagovit, B. Rosling, and Å. J. R. Möller. 1993. A comparison of two transport media for saliva and subgingival samples. Oral Microbiol. Immunol. 8:375-382[Medline]. |
| 6. | Hackman, A. S., and T. D. Wilkins. 1976. Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis in penicillin therapy of an experimental mixed anaerobic infection in mice. Arch. Oral Biol. 21:385-389[Medline]. |
| 7. | Hedberg, M., and C. E. Nord. 1996. Antimicrobial-resistant anaerobic bacteria in human infections. Med. Microbiol. Lett. 5:295-304. |
| 8. |
Heimdahl, A.,
L. von Konow, and C. E. Nord.
1981.
Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy.
J. Antimicrob. Chemother.
8:225-229 |
| 9. | Jousimies-Somer, H. R., P. H. Summanen, and S. M. Finegold. 1995. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-negative bacteria, p. 603-620. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. L. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C. |
| 10. | Könönen, E., A. Kanervo, A. Takala, S. Asikainen, and H. R. Jousimies-Somer. Establishment of oral anaerobes during the first year of life. J. Dent. Res., in press. |
| 11. | Könönen, E., M. Saarela, J. Karjalainen, H. Jousimies-Somer, S. Alaluusua, and S. Asikainen. 1994. Transmission of oral Prevotella melaninogenica between a mother and her young child. Oral Microbiol. Immunol. 9:304-310. |
| 12. |
Könönen, E.,
M. Saarela,
A. Kanervo,
J. Karjalainen,
S. Asikainen, and H. Jousimies-Somer.
1995.
-Lactamase production and penicillin susceptibility among different ribotypes of Prevotella melaninogenica simultaneously colonizing the oral cavity.
Clin. Infect. Dis.
20(Suppl. 2):S364-S366.
|
| 13. |
Könönen, E.,
S. Nyfors,
J. Mättö,
S. Asikainen, and H. Jousimies-Somer.
1997.
-Lactamase production among oral pigmented Prevotella species in young children.
Clin. Infect. Dis.
25(Suppl. 2):S272-S274.
|
| 14. |
Könönen, E.,
A. Kanervo,
K. Salminen, and H. Jousimies-Somer.
1999.
-Lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children.
Antimicrob. Agents Chemother.
43:1270-1273 |
| 15. | Kvaerner, K. J., P. Nafstad, J. Hagen, I. W. S. Mair, and J. J. K. Jaakkola. 1997. Early acute otitis media: determined by exposure to respiratory pathogens. Acta Oto-laryngol. 529(Suppl.):14-18. |
| 16. |
Murray, P. R., and J. E. Rosenblatt.
1977.
Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus.
Antimicrob. Agents Chemother.
11:605-608 |
| 17. | Nord, C. E., L. Kager, and A. Heimdahl. 1984. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am. J. Med. 15:99-106. |
| 18. | Rasmussen, B. A., K. Bush, and F. P. Tally. 1997. Antimicrobial resistance in anaerobes. Clin. Infect. Dis. 24(Suppl. 1):S110-S120. |
| 19. | Stark, C., C. Edlund, M. Hedberg, and C. E. Nord. 1995. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora. Eur. J. Clin. Microbiol. Infect. Dis. 14:18-24[Medline]. |
| 20. | Summanen, P., E. J. Baron, D. M. Citron, C. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif. |
| 21. |
Sykes, R. B., and M. Matthew.
1976.
The -lactamases of gram-negative bacteria and their role in resistance to -lactam antibiotics.
J. Antimicrob. Chemother.
2:115-157 |
| 22. | Teele, D. W., J. O. Klein, B. Rosner, and the Greater Boston Otitis Media Study Group. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160:83-94[Medline]. |
| 23. | Tunér, K., and C. E. Nord. 1983. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand. J. Infect. Dis. 39(Suppl.):83-85. |
| 24. | Walker, C. B. 1996. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol. 2000 10:79-88[Medline]. |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»